A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

I. C. Glitza; M. L. Rohlfs; M. Iqbal; J. Richard; E. Burton; S. Duncan; C. Brown; J. Anderson; P. Hwu; W. J. Hwu; M. Wong; C. Yee; S. Patel; S. Woodman; R. Amaria; A. Diab; H. Tawbi; M. Davies

doi:10.1093/annonc/mdy289.057

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

I. C. Glitza, M. L. Rohlfs, M. Iqbal, J. Richard, E. Burton, S. Duncan, C. Brown, J. Anderson, P. Hwu, W. J. Hwu, M. Wong, C. Yee, S. Patel, S. Woodman, R. Amaria, A. Diab, H. Tawbi, M. Davies

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	viii464
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy289.057
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy289.057

Cite this

Glitza, I. C., Rohlfs, M. L., Iqbal, M., Richard, J., Burton, E., Duncan, S., Brown, C., Anderson, J., Hwu, P., Hwu, W. J., Wong, M., Yee, C., Patel, S., Woodman, S., Amaria, R., Diab, A., Tawbi, H., & Davies, M. (2018). A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii464. https://doi.org/10.1093/annonc/mdy289.057

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD). / Glitza, I. C.; Rohlfs, M. L.; Iqbal, M. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii464.

Research output: Contribution to journal › Article › peer-review

Glitza, IC, Rohlfs, ML, Iqbal, M, Richard, J, Burton, E, Duncan, S, Brown, C, Anderson, J, Hwu, P, Hwu, WJ, Wong, M , Yee, C, Patel, S, Woodman, S , Amaria, R , Diab, A , Tawbi, H & Davies, M 2018, 'A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii464. https://doi.org/10.1093/annonc/mdy289.057

@article{b55edeb063d348028f20d6b6f2136d97,

title = "A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)",

author = "Glitza, {I. C.} and Rohlfs, {M. L.} and M. Iqbal and J. Richard and E. Burton and S. Duncan and C. Brown and J. Anderson and P. Hwu and Hwu, {W. J.} and M. Wong and C. Yee and S. Patel and S. Woodman and R. Amaria and A. Diab and H. Tawbi and M. Davies",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy289.057",

language = "English (US)",

volume = "29",

pages = "viii464",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

AU - Glitza, I. C.

AU - Rohlfs, M. L.

AU - Iqbal, M.

AU - Richard, J.

AU - Burton, E.

AU - Duncan, S.

AU - Brown, C.

AU - Anderson, J.

AU - Hwu, P.

AU - Hwu, W. J.

AU - Wong, M.

AU - Yee, C.

AU - Patel, S.

AU - Woodman, S.

AU - Amaria, R.

AU - Diab, A.

AU - Tawbi, H.

AU - Davies, M.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081531810&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy289.057

DO - 10.1093/annonc/mdy289.057

M3 - Article

C2 - 32137192

SN - 0923-7534

VL - 29

SP - viii464

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this